All Upcoming Events
VancouverVariational AI at WebSummit Vancouver 2026
Variational AI is joining Web Summit Vancouver 2026, one of the world’s premier technology conferences, bringing together over 20,000 attendees, investors, and innovators from across the globe, right here in Vancouver. Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, and Valentin Beuchillot, Senior Manager of BD & Marketing, will both be on the
San DiegoVariational AI at BIO International Convention 2026
Variational AI will be attending BIO International Convention 2026 in San Diego. We’ll be onsite for partnering meetings to connect with pharma and biotech teams interested in accelerating small-molecule programs with generative AI—especially where speed, novelty, and multi-parameter optimization are key. Our delegation will include: Handol Kim, CEO Pete Guzzo, EVP & Head of Drug
Learn More about Variational AI at BIO International Convention 2026
MontrealVariational AI at CCG’s North American UGM & Conference 2026
Variational AI will be at the CCG North American UGM & Conference in Montreal (June 23–26, 2026). Join Alex Perryman’s scientific presentation on June 25 on how MOE supported multiple drug discovery programs.
Learn More about Variational AI at CCG’s North American UGM & Conference 2026
BostonVariational AI at Discovery on Target 2026
Variational AI will participate in Discovery on Target (DOT) 2026, a leading conference dedicated to the latest advances in drug targets and enabling technologies for therapeutic discovery. Held annually in Boston, Discovery on Target brings together scientists from pharma, biotech, and academia to explore emerging approaches for identifying and validating novel drug targets, as well
CologneVariational AI at BIO-Europe 2026
Variational AI will participate in BIO-Europe 2026, one of the world’s leading partnering conferences for the biotechnology and pharmaceutical industries. The event brings together biotech companies, pharmaceutical firms, investors, and technology innovators from across the global life sciences ecosystem to explore partnerships, licensing opportunities, and new approaches to advancing therapeutic development. Meet the Variational AI
All Past Events
BostonVariational at Discovery on Target 2025
Variational is thrilled to be a part of Discovery on Target 2025, the top conference focused on novel drug targets and emerging discovery technologies. Our Head of Drug Discovery, Peter Guzzo will join peers from around the world to present our last poster and discuss the latest in target validation, biologics & small molecules. Let’s